Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency

Detalhes bibliográficos
Autor(a) principal: Kubaski, Francyne
Data de Publicação: 2022
Outros Autores: Burlina, Alberto, Trapp, Franciele Barbosa, Tirelli, Kristiane Michelin, Lopes, Franciele Fátima, Facchin, Ana Carolina Brusius, Netto, Alice Brinckmann Oliveira, Poletto, Édina, Giugliani, Roberto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/255488
Resumo: Background Acid sphingomyelinase deficiency (ASMD) is a lysosomal disorder caused by deficiency of acid sphingomyelinase (ASM) leading to the accumulation of sphingomyelin (SM) in a variety of cell types. Lysosphingomyelin (LysoSM) is the de-acetylated form of SM and it has been shown as a biomarker for ASMD in tissues, plasma, and dried blood spots (DBS) and lysosphingomyelin-509 (LysoSM509) is the carboxylated analogue of LysoSM. High levels of Lysosphingomyelin 509 (LysoSM509) have also been shown in ASMD patients. In this study, we report the utility of the quantification of LysoSM and LysoSM509 in DBS of patients from Latin America with ASMD by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Results DBS samples from 14 ASMD patients were compared with 15 controls, and 44 general newborns. All patients had their diagnosis confirmed by the quantification of ASM and the measurement of the activity of chitotriosidase. All patients had significantly higher levels of lysoSM and lysoSM509 compared to controls and general newborns. Conclusions The quantification of lysosphingolipids in DBS is a valuable tool for the diagnosis of ASMD patients and lysoSM can be useful in the differential diagnosis with NPC. This method is also valuable in the ASMD newborn screening process.
id UFRGS-2_3f0b970fc459a521af88bd51ef28a7f0
oai_identifier_str oai:www.lume.ufrgs.br:10183/255488
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Kubaski, FrancyneBurlina, AlbertoTrapp, Franciele BarbosaTirelli, Kristiane MichelinLopes, Franciele FátimaFacchin, Ana Carolina BrusiusNetto, Alice Brinckmann OliveiraPoletto, ÉdinaGiugliani, Roberto2023-03-10T03:25:25Z20221750-1172http://hdl.handle.net/10183/255488001160950Background Acid sphingomyelinase deficiency (ASMD) is a lysosomal disorder caused by deficiency of acid sphingomyelinase (ASM) leading to the accumulation of sphingomyelin (SM) in a variety of cell types. Lysosphingomyelin (LysoSM) is the de-acetylated form of SM and it has been shown as a biomarker for ASMD in tissues, plasma, and dried blood spots (DBS) and lysosphingomyelin-509 (LysoSM509) is the carboxylated analogue of LysoSM. High levels of Lysosphingomyelin 509 (LysoSM509) have also been shown in ASMD patients. In this study, we report the utility of the quantification of LysoSM and LysoSM509 in DBS of patients from Latin America with ASMD by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Results DBS samples from 14 ASMD patients were compared with 15 controls, and 44 general newborns. All patients had their diagnosis confirmed by the quantification of ASM and the measurement of the activity of chitotriosidase. All patients had significantly higher levels of lysoSM and lysoSM509 compared to controls and general newborns. Conclusions The quantification of lysosphingolipids in DBS is a valuable tool for the diagnosis of ASMD patients and lysoSM can be useful in the differential diagnosis with NPC. This method is also valuable in the ASMD newborn screening process.application/pdfengOrphanet journal of rare diseases. [London]. Vol. 17 (2022), 391, 23 p.BiomarcadoresDoenças de Niemann-PickDoenças por armazenamento dos lisossomosEspectrometria de massas em TandemAcid sphingomyelinase defciencyLysosphingomyelinTandem mass spectrometryBiomarkerNiemannPick type a/bQuantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiencyEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001160950.pdf.txt001160950.pdf.txtExtracted Texttext/plain32571http://www.lume.ufrgs.br/bitstream/10183/255488/2/001160950.pdf.txtbc63fdaec70f7f6972e69b36ec2db1f7MD52ORIGINAL001160950.pdfTexto completo (inglês)application/pdf1282451http://www.lume.ufrgs.br/bitstream/10183/255488/1/001160950.pdfaca00cbb8fbf9edbbdd29a9fdbdc762aMD5110183/2554882023-03-11 03:28:02.921423oai:www.lume.ufrgs.br:10183/255488Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2023-03-11T06:28:02Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency
title Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency
spellingShingle Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency
Kubaski, Francyne
Biomarcadores
Doenças de Niemann-Pick
Doenças por armazenamento dos lisossomos
Espectrometria de massas em Tandem
Acid sphingomyelinase defciency
Lysosphingomyelin
Tandem mass spectrometry
Biomarker
NiemannPick type a/b
title_short Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency
title_full Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency
title_fullStr Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency
title_full_unstemmed Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency
title_sort Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency
author Kubaski, Francyne
author_facet Kubaski, Francyne
Burlina, Alberto
Trapp, Franciele Barbosa
Tirelli, Kristiane Michelin
Lopes, Franciele Fátima
Facchin, Ana Carolina Brusius
Netto, Alice Brinckmann Oliveira
Poletto, Édina
Giugliani, Roberto
author_role author
author2 Burlina, Alberto
Trapp, Franciele Barbosa
Tirelli, Kristiane Michelin
Lopes, Franciele Fátima
Facchin, Ana Carolina Brusius
Netto, Alice Brinckmann Oliveira
Poletto, Édina
Giugliani, Roberto
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Kubaski, Francyne
Burlina, Alberto
Trapp, Franciele Barbosa
Tirelli, Kristiane Michelin
Lopes, Franciele Fátima
Facchin, Ana Carolina Brusius
Netto, Alice Brinckmann Oliveira
Poletto, Édina
Giugliani, Roberto
dc.subject.por.fl_str_mv Biomarcadores
Doenças de Niemann-Pick
Doenças por armazenamento dos lisossomos
Espectrometria de massas em Tandem
topic Biomarcadores
Doenças de Niemann-Pick
Doenças por armazenamento dos lisossomos
Espectrometria de massas em Tandem
Acid sphingomyelinase defciency
Lysosphingomyelin
Tandem mass spectrometry
Biomarker
NiemannPick type a/b
dc.subject.eng.fl_str_mv Acid sphingomyelinase defciency
Lysosphingomyelin
Tandem mass spectrometry
Biomarker
NiemannPick type a/b
description Background Acid sphingomyelinase deficiency (ASMD) is a lysosomal disorder caused by deficiency of acid sphingomyelinase (ASM) leading to the accumulation of sphingomyelin (SM) in a variety of cell types. Lysosphingomyelin (LysoSM) is the de-acetylated form of SM and it has been shown as a biomarker for ASMD in tissues, plasma, and dried blood spots (DBS) and lysosphingomyelin-509 (LysoSM509) is the carboxylated analogue of LysoSM. High levels of Lysosphingomyelin 509 (LysoSM509) have also been shown in ASMD patients. In this study, we report the utility of the quantification of LysoSM and LysoSM509 in DBS of patients from Latin America with ASMD by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Results DBS samples from 14 ASMD patients were compared with 15 controls, and 44 general newborns. All patients had their diagnosis confirmed by the quantification of ASM and the measurement of the activity of chitotriosidase. All patients had significantly higher levels of lysoSM and lysoSM509 compared to controls and general newborns. Conclusions The quantification of lysosphingolipids in DBS is a valuable tool for the diagnosis of ASMD patients and lysoSM can be useful in the differential diagnosis with NPC. This method is also valuable in the ASMD newborn screening process.
publishDate 2022
dc.date.issued.fl_str_mv 2022
dc.date.accessioned.fl_str_mv 2023-03-10T03:25:25Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/255488
dc.identifier.issn.pt_BR.fl_str_mv 1750-1172
dc.identifier.nrb.pt_BR.fl_str_mv 001160950
identifier_str_mv 1750-1172
001160950
url http://hdl.handle.net/10183/255488
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Orphanet journal of rare diseases. [London]. Vol. 17 (2022), 391, 23 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/255488/2/001160950.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/255488/1/001160950.pdf
bitstream.checksum.fl_str_mv bc63fdaec70f7f6972e69b36ec2db1f7
aca00cbb8fbf9edbbdd29a9fdbdc762a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801225082530430976